{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:34:49Z","timestamp":1789774489396,"version":"4.0.1"},"reference-count":33,"publisher":"Medical Association of Nippon Medical School","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2023,10,25]]},"DOI":"10.1272\/jnms.jnms.2023_90-406","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T22:11:18Z","timestamp":1699308678000},"page":"387-397","source":"Crossref","is-referenced-by-count":2,"title":["Dexmedetomidine Might Exacerbate Acute Kidney Injury, While Midazolam Might Have a Postconditioning Effect: A Rat Model of Lipopolysaccharide-Induced Acute Kidney Injury"],"prefix":"10.1272","volume":"90","author":[{"given":"Akiko","family":"Hata","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masae","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiro","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016 Feb 1;193 (3):259-72.","DOI":"10.1164\/rccm.201504-0781OC"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gomez H, Kellum JA. Sepsis-induced acute kidney injury. Curr Opin Crit Care. 2016 Dec;22 (6):546-53.","DOI":"10.1097\/MCC.0000000000000356"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yasuda H, Kato A, Fujigaki Y, Hishida A; Shizuoka Kidney Disease Study Group. Incidence and clinical outcomes of acute kidney injury requiring renal replacement therapy in Japan. Ther Apher Dial. 2010 Dec;14 (6):541-6.","DOI":"10.1111\/j.1744-9987.2010.00826.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Matsuda A, Jacob A, Wu R, et al. Novel therapeutic targets for sepsis: regulation of exaggerated inflammatory responses. J Nippon Med Sch. 2012;79 (1):4-18.","DOI":"10.1272\/jnms.79.4"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chen Y, Luan L, Wang C, et al. Dexmedetomidine protects against lipopolysaccharide-induced early acute kidney injury by inhibiting the iNOS\/NO signaling pathway in rats. Nitric Oxide. 2019 Apr 1;85:1-9.","DOI":"10.1016\/j.niox.2019.01.009"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Feng X, Guan W, Zhao Y, et al. Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3 beta\/Nrf2 signaling pathway. J Cell Physiol. 2019 Aug;234 (10):18994-9009.","DOI":"10.1002\/jcp.28539"},{"key":"7","unstructured":"7. Jin YH, Li ZT, Chen H, Jiang XQ, Zhang YY, Wu F. Effect of dexmedetomidine on kidney injury in sepsis rats through TLR4\/MyD88\/NF-kappaB\/iNOS signaling pathway. Eur Rev Med Pharmacol Sci. 2019 Jun;23 (11):5020-5."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kiyonaga N, Moriyama T, Kanmura Y. Effects of dexmedetomidine on lipopolysaccharide-induced acute kidney injury in rats and mitochondrial function in cell culture. Biomed Pharmacother. 2020 May;125:109912. Epub 2020 Jan 31.","DOI":"10.1016\/j.biopha.2020.109912"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tan F, Chen Y, Yuan D, Gong C, Li X, Zhou S. Dexmedetomidine protects against acute kidney injury through downregulating inflammatory reactions in endotoxemia rats. Biomed Rep. 2015 May;3 (3):365-70. Epub 2015 Feb 12.","DOI":"10.3892\/br.2015.427"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yang T, Feng X, Zhao Y, et al. Dexmedetomidine enhances autophagy via alpha2-AR\/AMPK\/mTOR pathway to inhibit the activation of NLRP3 inflammasome and subsequently alleviates lipopolysaccharide-induced acute kidney injury. Front Pharmacol. 2020;11:790.","DOI":"10.3389\/fphar.2020.00790"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yao Y, Hu X, Feng X, et al. Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4\/NOX4\/NF-kappaB pathway. J Cell Biochem. 2019 Oct;120 (10):18509-23. Epub 2019 Jun 26.","DOI":"10.1002\/jcb.29173"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zhao Y, Feng X, Li B, et al. Dexmedetomidine protects against lipopolysaccharide-induced acute kidney injury by enhancing autophagy through inhibition of the PI3K\/AKT\/mTOR pathway. Front Pharmacol. 2020;11:128.","DOI":"10.3389\/fphar.2020.00128"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Cui WY, Tian AY, Bai T. Protective effects of propofol on endotoxemia-induced acute kidney injury in rats. Clin Exp Pharmacol Physiol. 2011 Nov;38 (11):747-54.","DOI":"10.1111\/j.1440-1681.2011.05584.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Percie du Sert N, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020 Jul;18 (7):e3000410.","DOI":"10.1371\/journal.pbio.3000410"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Plotnikov EY, Brezgunova AA, Pevzner IB, et al. Mechanisms of LPS-induced acute kidney injury in neonatal and adult rats. Antioxidants (Basel). 2018 Aug 8;7 (8):105.","DOI":"10.3390\/antiox7080105"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Takemoto Y. Dose effects of propofol on hemodynamic and cytokine responses to endotoxemia in rats. J Anesth. 2005;19 (1):40-4.","DOI":"10.1007\/s00540-004-0267-z"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Taniguchi T, Kanakura H, Yamamoto K. Effects of posttreatment with propofol on mortality and cytokine responses to endotoxin-induced shock in rats. Crit Care Med. 2002 Apr;30 (4):904-7.","DOI":"10.1097\/00003246-200204000-00032"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Taniguchi T, Yamamoto K, Ohmoto N, Ohta K, Kobayashi T. Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats. Crit Care Med. 2000 Apr;28 (4):1101-6.","DOI":"10.1097\/00003246-200004000-00032"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Qiao H, Sanders RD, Ma D, Wu X, Maze M. Sedation improves early outcome in severely septic Sprague Dawley rats. Crit Care. 2009;13 (4):R136. Epub 2009 Aug 19.","DOI":"10.1186\/cc8012"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sotocinal SG, Sorge RE, Zaloum A, et al. The rat grimace scale: a partially automated method for quantifying pain in the laboratory rat via facial expressions. Mol Pain. 2011 Jul 29;7:55.","DOI":"10.1186\/1744-8069-7-55"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Matsuzaki T, Ozawa H. Multiple immunofluorescence labeling in tissue sections. J Nippon Med Sch. 2009 Dec;76 (6):278-9.","DOI":"10.1272\/jnms.76.278"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Shehabi Y, Howe BD, Bellomo R, et al. Early sedation with dexmedetomidine in critically ill patients. N Engl J Med. 2019 Jun 27;380 (26):2506-17. Epub 2019 May 19.","DOI":"10.1056\/NEJMoa1904710"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Plummer MP, Lankadeva YR, Finnis ME, et al. Urinary and renal oxygenation during dexmedetomidine infusion in critically ill adults with mechanistic insights from an ovine model. J Crit Care. 2021 Aug;64:74-81. Epub 2021 Mar 24.","DOI":"10.1016\/j.jcrc.2021.03.004"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Cummins EP, Berra E, Comerford KM, et al. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci U S A. 2006 Nov 28;103 (48):18154-9. Epub 2006 Nov 17.","DOI":"10.1073\/pnas.0602235103"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Joo HK, Oh SC, Cho EJ, et al. Midazolam inhibits tumor necrosis factor-alpha-induced endothelial activation: involvement of the peripheral benzodiazepine receptor. Anesthesiology. 2009 Jan;110 (1):106-12.","DOI":"10.1097\/ALN.0b013e318190bc69"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Horiguchi Y, Ohta N, Yamamoto S, Koide M, Fujino Y. Midazolam suppresses the lipopolysaccharide-stimulated immune responses of human macrophages via translocator protein signaling. Int Immunopharmacol. 2019 Jan;66:373-82. Epub 2018 Dec 5.","DOI":"10.1016\/j.intimp.2018.11.050"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell. 2008 Feb 8;132 (3):344-62.","DOI":"10.1016\/j.cell.2008.01.020"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Mitchell S, Vargas J, Hoffmann A. Signaling via the NFkappaB system. Wiley Interdiscip Rev Syst Biol Med. 2016 May;8 (3):227-41. Epub 2016 Mar 16.","DOI":"10.1002\/wsbm.1331"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Khwaja A. KDIGO Clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120 (4):c179-84. Epub 2012 Aug 7.","DOI":"10.1159\/000339789"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Sandilands EA, Dhaun N, Dear JW, Webb DJ. Measurement of renal function in patients with chronic kidney disease. Br J Clin Pharmacol. 2013 Oct;76 (4):504-15.","DOI":"10.1111\/bcp.12198"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Teo SH, Endre ZH. Biomarkers in acute kidney injury (AKI). Best Pract Res Clin Anaesthesiol. 2017 Sep;31 (3):331-44.","DOI":"10.1016\/j.bpa.2017.10.003"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Ahlstr\u00f6m A, Tallgren M, Peltonen S, Pettil\u00e4 V. Evolution and predictive power of serum cystatin C in acute renal failure. Clin Nephrol. 2004 Nov;62 (5):344-50.","DOI":"10.5414\/CNP62344"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Ortuno-Anderiz F, Cabello-Clotet N, Vidart-Simon N, Postigo-Hernandez C, Domingo-Marin S, Sanchez-Garcia M. Cystatin C as an early marker of acute kidney injury in septic shock. Rev Clin Esp (Barc). 2015 Mar;215 (2):83-90. English, Spanish. Epub 2014 Nov 13.","DOI":"10.1016\/j.rceng.2014.09.001"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/90\/5\/90_JNMS.2023_90-406\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T04:04:54Z","timestamp":1699675494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/90\/5\/90_JNMS.2023_90-406\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,25]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2023_90-406","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,25]]},"article-number":"JNMS.2023_90-406"}}